Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × enzalutamide × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

INDUSTRY 70 OTHER 61 NIH 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Radiotherapy 192 Cisplatin 166 Cyclophosphamide 147 Doxorubicin 120 Paclitaxel 115 Vincristine 107 Filgrastim 105 Etoposide 90 Carboplatin 90 Gemcitabine 74 Methotrexate 73 Docetaxel 70 Fluorouracil 68 Cytarabine 67 Gene Expression Profiling 66 Prednisone 62 Dexamethasone 62 Granulocyte Colony-Stimulating Factor 58 Leucovorin 54 Polymerase Chain Reaction 42 Immunohistochemistry 42 Microarray Analysis 38 Ifosfamide 35 Irinotecan 34 Daunorubicin 33 Temozolomide 32 Amplified Fragment Length Polymorphism Analysis 30 Cetuximab 29 Capecitabine 29 Flow Cytometry 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02225704 2023-04-06

Radium-223 in Combination With Enzalutamide

Cancer Trials Ireland

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡